Baxa Features Exacta-Med® And Closed System Technology For Safe Handling And Administration Of Fluid Drugs At Interphex 2005
Baxa Corporation will present its proprietary systems designed to enhance the safety and efficiency of fluid medication handling and delivery at the 26th annual Interphex Conference and Exhibition -- April 26 – 28 at the Jacob K. Javits Center in New York. Its Exacta-Med products offer added value to packaged pharmaceuticals as part of a complete drug delivery system.
Denver, CO, April 26, 2005 --(PR.com)-- At the 26th annual Interphex Conference and Exhibition, Baxa Corporation will present its proprietary systems designed to enhance the safety and efficiency of fluid medication handling and delivery. Its Exacta-Med products offer added value to packaged pharmaceuticals as part of a complete drug delivery system.
Closed system technology (CST) for safe handling of antineoplastic and other hazardous drugs, has been documented to reduce or eliminate human exposure to toxic hazards in the workplace. The system allows healthcare workers to reconstitute, transport, and administer hazardous drugs without risk of environmental contamination. Closed systems are recommended by the National Institute for Occupational Safety and Health (NIOSH) in its 2004 Alert to prevent occupational and environmental exposure to hazardous drugs.
Exacta-Med Dispensers provide safe oral and enteral medication delivery by eliminating the risk of wrong-route administration. The system’s non-luer components cannot actuate a needleless valve or connect to a hypodermic needle or fitting. Oral dispensers are recommended by the Institute for Safe Medication Practices (ISMP) to reduce the opportunity for med errors.
Interphex 2005, held April 26 – 28 at the Jacob K. Javits Center in New York, brings together global companies serving the pharmaceutical and biotechnical industries. This year’s exhibition is paired with an application-oriented conference to help industry professionals develop critical on-the-job skills.
“Interphex offers Baxa an opportunity to find pharmaceutical partners,” states Joyce Federer, Director of OEM Sales, “Our goal is to help other manufacturers create greater product value for mature products, improve the safety of their medication delivery, or to improve the outcomes of their clinical trials. Baxa, with thirty years’ experience in the hospital pharmacy, is in a unique position to offer regulatory expertise and market knowledge that can assist other companies in the development of specialized products for drug delivery applications, or to add value through improved patient safety and compliance.”
Founded in 1975, Baxa Corporation built its reputation by designing niche products that provide solutions for the transfer, delivery, packaging and administration of fluid medications in hospital pharmacy and alternate-site settings worldwide. The company is certified to the quality standards for ISO 13485 and EN46001.
About Baxa Corporation
Celebrating 30 years of business in 2005, Baxa Corporation is a Denver-based manufacturer of medical devices and systems for preparing, handling, packaging, and administering liquid medications. The company manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada, the United Kingdom; Denmark, and Germany; and distribution partners worldwide. Further information is available at http://www.baxa.com.
About Interphex 2005
The world’s largest and most comprehensive pharmaceutical conference and exhibition is held annually at the Jacob K. Javits Center. Sponsored by Reed Exhibitions, the meeting features 1,000 global exhibitors in the areas of PharmaManufacturing, PharmaSourcing & Services, PharmaIT and PharmaFacilities. Further information is available at http://www.interphex.com.
Click the following link to view a presentation by Jim Jorgenson "Using a Closed System Device to Reduce Occupational Exposure to Hazardous Drugs." Jorgenson is Director of Pharmacy for the Huntsman Cancer Institute and Associate Dean for Professional Affairs at the University of Utah:
http://www.isips.org/presentations/PhaSeal/player.html
Contacts:
Marian Robinson
Vice President, Marketing
Baxa Corporation
800.567.2292 ext. 2157
or 303.617.2157
Maggie Chamberlin Holben, APR
Absolutely Public Relations
303.984.9801
or 303.669.3558
###
Closed system technology (CST) for safe handling of antineoplastic and other hazardous drugs, has been documented to reduce or eliminate human exposure to toxic hazards in the workplace. The system allows healthcare workers to reconstitute, transport, and administer hazardous drugs without risk of environmental contamination. Closed systems are recommended by the National Institute for Occupational Safety and Health (NIOSH) in its 2004 Alert to prevent occupational and environmental exposure to hazardous drugs.
Exacta-Med Dispensers provide safe oral and enteral medication delivery by eliminating the risk of wrong-route administration. The system’s non-luer components cannot actuate a needleless valve or connect to a hypodermic needle or fitting. Oral dispensers are recommended by the Institute for Safe Medication Practices (ISMP) to reduce the opportunity for med errors.
Interphex 2005, held April 26 – 28 at the Jacob K. Javits Center in New York, brings together global companies serving the pharmaceutical and biotechnical industries. This year’s exhibition is paired with an application-oriented conference to help industry professionals develop critical on-the-job skills.
“Interphex offers Baxa an opportunity to find pharmaceutical partners,” states Joyce Federer, Director of OEM Sales, “Our goal is to help other manufacturers create greater product value for mature products, improve the safety of their medication delivery, or to improve the outcomes of their clinical trials. Baxa, with thirty years’ experience in the hospital pharmacy, is in a unique position to offer regulatory expertise and market knowledge that can assist other companies in the development of specialized products for drug delivery applications, or to add value through improved patient safety and compliance.”
Founded in 1975, Baxa Corporation built its reputation by designing niche products that provide solutions for the transfer, delivery, packaging and administration of fluid medications in hospital pharmacy and alternate-site settings worldwide. The company is certified to the quality standards for ISO 13485 and EN46001.
About Baxa Corporation
Celebrating 30 years of business in 2005, Baxa Corporation is a Denver-based manufacturer of medical devices and systems for preparing, handling, packaging, and administering liquid medications. The company manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada, the United Kingdom; Denmark, and Germany; and distribution partners worldwide. Further information is available at http://www.baxa.com.
About Interphex 2005
The world’s largest and most comprehensive pharmaceutical conference and exhibition is held annually at the Jacob K. Javits Center. Sponsored by Reed Exhibitions, the meeting features 1,000 global exhibitors in the areas of PharmaManufacturing, PharmaSourcing & Services, PharmaIT and PharmaFacilities. Further information is available at http://www.interphex.com.
Click the following link to view a presentation by Jim Jorgenson "Using a Closed System Device to Reduce Occupational Exposure to Hazardous Drugs." Jorgenson is Director of Pharmacy for the Huntsman Cancer Institute and Associate Dean for Professional Affairs at the University of Utah:
http://www.isips.org/presentations/PhaSeal/player.html
Contacts:
Marian Robinson
Vice President, Marketing
Baxa Corporation
800.567.2292 ext. 2157
or 303.617.2157
Maggie Chamberlin Holben, APR
Absolutely Public Relations
303.984.9801
or 303.669.3558
###
Contact
Baxa Corporation
Maggie Chamberlin Holben, APR
303.984.9801 or 303.669.3558
http://www.baxa.com
Maggie Chamberlin Holben, APR
303.984.9801 or 303.669.3558
http://www.baxa.com
Contact
Categories